Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.
Emma Puighermanal, Arnau Busquets-García, Rafaël Maldonado, Andrés Ozaita
Philosophical transactions of the Royal Society of London. Series B, Biological sciences December 5, 2012 DOI: 10.1098/rstb.2011.0384 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | The review contends that cannabinoid effects on learning and memory are mediated through cannabinoid receptor activation and downstream signalling, particularly the mTOR pathway and extracellular signal-regulated kinases (ERK), with consequent regulation of protein translation playing a critical role in the amnesic-like effects of cannabinoids. |
Abstract
Exogenous cannabinoids, such as delta9-tetrahydrocannabinol (THC), as well as the modulation of endogenous cannabinoids, affect cognitive function through the activation of cannabinoid receptors. Indeed, these compounds modulate a number of signalling pathways critically implicated in the deleterious effect of cannabinoids on learning and memory. Thus, the involvement of the mammalian target of rapamycin pathway and extracellular signal-regulated kinases, together with their consequent regulation of cellular processes such as protein translation, play a critical role in the amnesic-like effects of cannabinoids. In this study, we summarize the cellular and molecular mechanisms reported in the modulation of cognitive function by the endocannabinoid system.
Citations in the library
Cited by 8
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors PLoS Biology July 9, 2015
- Psychedelics in neuroinflammation: Mechanisms and therapeutic potential Progress in Neuro-Psychopharmacology and Biological Psychiatry January 31, 2025
- Sex differences in the acute effects of cannabis on human cognition: A systematic review. Frontiers in neuroendocrinology October 1, 2025
- Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration. International Journal of Molecular Sciences May 9, 2026
- Δ9-tetrahydrocannabinol modulates the proteasome system in the brain. Biochemical Pharmacology November 2018
and 3 more in the library
Cites 10
- Effects of Endocannabinoid System Modulation on Cognitive and Emotional Behavior Frontiers in Behavioral Neuroscience July 22, 2011
- An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of Addiction Medicine March 2011
- Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity. Journal of Neurochemistry February 2010
- Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology 2010
- Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biology October 2007
and 5 more in the library